Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Medytox

Medytox Daewoong Pharmaceutical’s 2nd largest shareholder in the US partner

Medytox Daewoong Pharmaceutical’s 2nd largest shareholder in the US partner

Medytox acquires shares of Daewoong Pharmaceutical’s U.S. partner Evolu, becoming the second largest shareholder

Medytox acquires shares of Daewoong Pharmaceutical’s U.S. partner Evolu, becoming the second largest shareholder

[특징주] Medytox, upper limit on news of’US Botox dispute’ agreement (general)

[특징주] Medytox, upper limit on news of’US Botox dispute’ agreement (general)

‘Botox War’ Medytox and Daewoong agreed to dispute with the US…  Notice of bleeding again for domestic flights

‘Botox War’ Medytox and Daewoong agreed to dispute with the US… Notice of bleeding again for domestic flights

[특징주] Medytox,’upper limit’ on news of’US Botox dispute’ agreement

[특징주] Medytox,’upper limit’ on news of’US Botox dispute’ agreement

[특징주] Medytox, intraday ceiling on news of’US Botox dispute’

[특징주] Medytox, intraday ceiling on news of’US Botox dispute’

[특징주] Medytox, intraday ceiling on news of’US Botox dispute’

[특징주] Medytox, intraday ceiling on news of’US Botox dispute’

Compensation + Loyalty + Stock…  Medytox in the wake of the’Botox War’-JoongAng Ilbo

Compensation + Loyalty + Stock… Medytox in the wake of the’Botox War’-JoongAng Ilbo

Medytox and Daewoong settle ITC litigation with three-party agreement…  Domestic trial continues

Medytox and Daewoong settle ITC litigation with three-party agreement… Domestic trial continues

Medytox and Daewoong settle ITC litigation with three-party agreement…  Domestic trial continues

Medytox and Daewoong settle ITC litigation with three-party agreement… Domestic trial continues

Daewoong Pharmaceutical, operating profit of 17 billion won last year…  62% decrease from the previous year

Daewoong Pharmaceutical, operating profit of 17 billion won last year… 62% decrease from the previous year

Daewoong Pharmaceutical’s “Meditox ITC judgment interpretation, false claims and distortions”

Daewoong Pharmaceutical’s “Meditox ITC judgment interpretation, false claims and distortions”

Older posts
Page1 Page2 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en